Clinical trials
Phase 3 Autoimmune Diseases trials in Italy
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
18 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2008 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2013 | 2 |
| 2015 | 1 |
| 2022 | 2 |
| 2023 | 2 |
| 2024 | 2 |
| 2025 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 8 |
| Recruiting | 6 |
| Active, not recruiting | 2 |
| Terminated | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Human Genome Sciences Inc., a GSK Company | 3 |
| Immunovant Sciences GmbH | 3 |
| Takeda | 2 |
| AstraZeneca | 1 |
| Baxalta now part of Shire | 1 |
| Bristol-Myers Squibb | 1 |
| Eli Lilly and Company | 1 |
| GlaxoSmithKline | 1 |
| Human Genome Sciences Inc. | 1 |
| Kedrion S.p.A. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Autoimmune Diseases | 18 |
| Immune System Diseases | 7 |
| Lupus Erythematosus, Systemic | 6 |
| Connective Tissue Diseases | 3 |
| Hematologic Diseases | 3 |
| Hemorrhagic Disorders | 3 |
| Purpura, Thrombocytopenic, Idiopathic | 3 |
| Blood Platelet Disorders | 2 |
| Cytopenia | 2 |
| Graves Ophthalmopathy | 2 |
Trials
Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.